Development Level

Tbio 7 | 11,445
Tchem 4 | 1,598
Tclin 4 | 613

IMPC Phenotype

decreased circulating insulin ... 2 | 76
abnormal behavioral response t... 1 | 66
abnormal epididymis morphology 1 | 42
abnormal heart morphology 1 | 162
abnormal lung morphology 1 | 26
abnormal seminal vesicle morph... 1 | 114
abnormal spleen morphology 1 | 55
abnormal testis morphology 1 | 43
decreased bone mineral density 1 | 126
decreased circulating magnesiu... 1 | 13
decreased mean corpuscular vol... 1 | 79
enlarged epididymis 1 | 31
enlarged heart 1 | 210
enlarged heart atrium 1 | 4
enlarged spleen 1 | 41
improved glucose tolerance 1 | 79
increased circulating glycerol... 1 | 9
increased mean corpuscular vol... 1 | 92
small seminal vesicle 1 | 10
small testis 1 | 58

Disease

ovarian cancer 10 | 8,520
Carcinoma 9 | 11,493
Cancer 7 | 2,499
glioblastoma 7 | 5,792
lung cancer 7 | 4,740
malignant mesothelioma 7 | 3,232
medulloblastoma, large-cell 7 | 6,241
osteosarcoma 7 | 7,950
tuberculosis 7 | 2,010
ependymoma 6 | 4,679
psoriasis 6 | 6,694
atypical teratoid / rhabdoid tumor 5 | 5,112
group 3 medulloblastoma 5 | 4,104
intraductal papillary-mucinous carcinoma (IPMC) 5 | 2,989
lung carcinoma 5 | 2,843
pituitary cancer 5 | 1,972
Astrocytoma, Pilocytic 4 | 3,081
Breast cancer 4 | 3,578
Lung Neoplasms 4 | 232
Prostatic Neoplasms 4 | 495
adult high grade glioma 4 | 3,801
interstitial cystitis 4 | 2,312
intraductal papillary-mucinous adenoma (IPMA) 4 | 2,955
intraductal papillary-mucinous neoplasm (IPMN) 4 | 3,291
Kidney cancer 3 | 2,613
Schizophrenia 3 | 1,160
acute quadriplegic myopathy 3 | 1,158
autosomal dominant Emery-Dreifuss muscular dystrophy 3 | 510
cystic fibrosis 3 | 1,696
diabetes mellitus 3 | 1,728
non diabetic and post-ischemic heart failure 3 | 200
non primary Sjogren syndrome sicca 3 | 891
oligodendroglioma 3 | 2,850
pancreatic ductal adenocarcinoma liver metastasis 3 | 1,962
primitive neuroectodermal tumor 3 | 3,035
subependymal giant cell astrocytoma 3 | 2,287
Adenocarcinoma 2 | 122
Adenoma 2 | 167
Adverse reaction to drug 2 | 61
Anemia 2 | 365
Anorexia 2 | 43
Atopic dermatitis 2 | 952
Bladder Neoplasm 2 | 112
Breast Neoplasms 2 | 445
Carcinoma, Hepatocellular 2 | 228
Carcinoma, Transitional Cell 2 | 32
Colonic Neoplasms 2 | 142
Colorectal Neoplasms 2 | 243
Drug-Related Side Effects and Adverse Reactions 2 | 62
Duchenne muscular dystrophy 2 | 601
Endometrial cancer 2 | 311
Esophageal Squamous Cell Carcinoma 2 | 77
Esophagitis 2 | 35
Fatigue 2 | 182
Gastroesophageal reflux disease 2 | 110
Hyperparathyroidism 2 | 48
Immune system cancer 2 | 140
Kidney Diseases 2 | 114
Liver Neoplasms, Experimental 2 | 59
Liver carcinoma 2 | 240
Liver neoplasms 2 | 130
Lymphoid leukemia 2 | 160
Lymphoma, Non-Hodgkin 2 | 24
Mantle cell lymphoma 2 | 23
Multiple myeloma 2 | 1,332
Papilloma 2 | 44
Parathyroid Adenoma 2 | 19
Peptic Ulcer 2 | 27
Splenomegaly 2 | 190
Squamous cell carcinoma of esophagus 2 | 77
Stomach Neoplasms 2 | 300
Urinary Bladder Neoplasms 2 | 114
Zollinger-Ellison syndrome 2 | 18
astrocytoma 2 | 1,146
ductal carcinoma in situ 2 | 1,745
gastric cancer 2 | 459
head and neck cancer and chronic obstructive pulmonary disease 2 | 239
invasive ductal carcinoma 2 | 2,951
juvenile dermatomyositis 2 | 1,187
limb girdle muscular dystrophy 2A 2 | 213
mucosa-associated lymphoid tissue lymphoma 2 | 484
nasopharyngeal carcinoma 2 | 1,058
primary pancreatic ductal adenocarcinoma 2 | 1,109
type II diabetes mellitus and post-ischemic heart failure 2 | 88
Bone Marrow Diseases 1 | 7
Brain Neoplasms 1 | 33
Decreased visual acuity, slowly progressive 1 | 13
Hyperinsulinaemic hypoglycaemia 1 | 16
Increased serum parathyroid hormone 1 | 14
Leber hereditary optic neuropathy 1 | 14
Lymphoma, Mantle-Cell 1 | 11
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse 1 | 12
Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes 1 | 9
Mitochondrial myopathy 1 | 26
Neurodegenerative Diseases 1 | 38
Prolactinoma 1 | 11
Sensorineural hearing loss, bilateral 1 | 18
Slow decrease in visual acuity 1 | 13
Substance abuse 1 | 59
acute T cell leukemia 1 | 17

Tissue

Blood and immune system 15 | 16,909
Digestive Tract 15 | 17,369
Endocrine System 15 | 18,159
Female tissues 15 | 17,400
Male tissues 15 | 17,142
Nervous System 15 | 16,725
Urinary Tract 15 | 16,678
Liver and Pancreas 14 | 16,750
Respiratory system 14 | 16,393
Skin and soft tissues 14 | 17,230
Cardiovascular System 13 | 15,192

Target Family

Enzyme 7 | 4,145
Non-IDG 4 | 12,091
Transporter 2 | 473
Kinase 1 | 634
Transcription Factor 1 | 1,400

GO Process

response to organonitrogen com... 15 | 15
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
FUN14 domain-containing protein 1 FUNDC1 Tbio Non-IDG -1.21206 16.0 151
Potassium-transporting ATPase subunit beta ATP4B Tclin Transporter -0.89031 7.06 189
Nicotinamide N-methyltransferase NNMT Tchem Enzyme -2.09313 121.9 268
Multidrug resistance-associated protein 4 ABCC4 Tchem Transporter -2.56001 341.6 352
Tumor protein p73 TP73 Tbio Transcription Factor -1.92832 82.6 708
Microsomal glutathione S-transferase 1 MGST1 Tbio Enzyme -2.30082 197.5 146
Receptor-type tyrosine-protein kinase FLT3 FLT3 Tclin Kinase -3.31736 2112.7 1076
Microsomal glutathione S-transferase 2 MGST2 Tbio Enzyme -1.15686 13.6 120
G1/S-specific cyclin-D1 CCND1 Tchem Non-IDG -3.82232 5737.3 1312
Cyclin-dependent kinase inhibitor 1 CDKN1A Tbio Enzyme -3.43737 3042.8 1509